LifeShare Blood Centers FDA Inspection Record
LifeShare Blood Centers is an FDA-inspected facility (FEI 2377737) located in Lake Charles, LA, US. RegDataLab tracks 6 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Apr 4, 2023: No Action Indicated (NAI)
- Inspections on record
- 6 (6 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 12, latest Dec 4, 2024
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Apr 4, 2023 | No Action Indicated (NAI) | No citations listed |
| Oct 18, 2017 | No Action Indicated (NAI) | No citations listed |
| Sep 8, 2016 | No Action Indicated (NAI) | No citations listed |
| Oct 30, 2014 | No Action Indicated (NAI) | No citations listed |
| Dec 19, 2012 | No Action Indicated (NAI) | No citations listed |
| Dec 4, 2008 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Dec 4, 2024 | Class III | B-0154-2025 | Red Blood Cells, Leukocytes Reduced Leukoreduced Red Blood Cells, collected from a donor who lacked documentation of arm inspection on the donor history questionnaire, were… |
| Jul 3, 2019 | Class III | B-0835-2019 | Red Blood Cells, Leukocytes Reduced Red Blood Cell product in which Donor Screening/Donor record was incomplete, was distributed. |
| Jun 28, 2018 | Class II | B-0018-2019 | Apheresis Platelets, Leukocytes Reduced and 2 more products Blood products, collected from an ineligible donor, were distributed. |
| May 18, 2018 | Class II | B-0021-2019 | Red Blood Cells, Leukocytes Reduced and 1 more product Blood products, collected from an ineligible donor, were distributed. |
| Sep 13, 2017 | Class II | B-0272-2018 | Apheresis Red Blood Cells, Leukocytes Reduced Blood product, collected from a donor who traveled to a malarial endemic area, was distributed. |
| Apr 13, 2016 | Class II | B-0472-16 | Red Blood Cells, Leukocytes Reduced Blood Product collected from a donor who traveled to a malarial endemic area was distributed. |
| Mar 11, 2016 | Class II | B-0534-16 | Red Blood Cells, Leukocytes Reduced Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed. |
| Mar 9, 2016 | Class II | B-0575-16 | Blood and Blood Products for Reprocessing Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed. |
| Feb 20, 2015 | Class III | B-0899-15 | Red Blood Cells Leukocytes Reduced Blood product, collected from a donor who was at risk for leishmaniasis, was distributed. |
| Sep 4, 2012 | Class II | B-0313-13 | Red Blood Cells Leukocytes Reduced and 1 more product Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. |
FDA record score
3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
9 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall B-0018-2019, this FEI as the recalling firm | Jun 28, 2018 | 4 x 0.25 | 1 |
| Class II recall B-0021-2019, this FEI as the recalling firm | May 18, 2018 | 4 x 0.25 | 1 |
| Class II recall B-0272-2018, this FEI as the recalling firm | Sep 13, 2017 | 4 x 0.25 | 1 |
| Class II recall B-0472-16, this FEI as the recalling firm | Apr 13, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0534-16, this FEI as the recalling firm | Mar 11, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0575-16, this FEI as the recalling firm | Mar 9, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0313-13, this FEI as the recalling firm | Sep 4, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1789-3, this FEI as the recalling firm | Apr 30, 2003 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1253-3, this FEI as the recalling firm | Feb 6, 2001 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 17, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 17, 2026 | Newest record Nov 16, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing LifeShare Blood Centers as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check LifeShare Blood Centers yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- LifeShare Blood Centers
- Location
- Lake Charles, LA (US)
- Source
- inspections